Identification of paired-related Homeobox Protein 1 as a key mesenchymal transcription factor in pulmonary fibrosis

  1. Emmeline Marchal-Duval
  2. Méline Homps-Legrand
  3. Antoine Froidure
  4. Madeleine Jaillet
  5. Mada Ghanem
  6. Deneuville Lou
  7. Aurélien Justet
  8. Arnaud Maurac
  9. Aurelie Vadel
  10. Emilie Fortas
  11. Aurelie Cazes
  12. Audrey Joannes
  13. Laura Giersh
  14. Herve Mal
  15. Pierre Mordant
  16. Tristan Piolot
  17. Marin Truchin
  18. Carine M Mounier
  19. Ksenija Schirduan
  20. Martina Korfei
  21. Andreas Gunther
  22. Bernard Mari
  23. Frank Jaschinski
  24. Bruno Crestani
  25. Arnaud A Mailleux  Is a corresponding author
  1. Université Paris Cité, Inserm, France
  2. Université Catholique de Louvain, Belgium
  3. Univ Rennes, Inserm, EHESP, France
  4. Assistance Publique - Hôpitaux de Paris, France
  5. Collège de France, CNRS-UMR7241, INSERM-U1050, PSL Research University,, France
  6. Université Côte d'Azur, CNRS, France
  7. Secarna Pharmaceuticals GmbH and Co KG, Germany
  8. University of Giessen, Germany

Abstract

Matrix remodeling is a salient feature of idiopathic pulmonary fibrosis (IPF). Targeting cells driving matrix remodeling could be a promising avenue for IPF treatment. Analysis of transcriptomic database identified the mesenchymal transcription factor PRRX1 as upregulated in IPF. PRRX1, strongly expressed by lung fibroblasts, was regulated by a TGF-b/PGE2 balance in vitro in control and IPF human lung fibroblasts, while IPF fibroblast-derived matrix increased PRRX1 expression in a PDGFR dependent manner in control ones. PRRX1 inhibition decreased human lung fibroblast proliferation by downregulating the expression of S phase cyclins. PRRX1 inhibition also impacted TGF-β driven myofibroblastic differentiation by inhibiting SMAD2/3 phosphorylation through phosphatase PPM1A upregulation and TGFBR2 downregulation, leading to TGF-β response global decrease. Finally, targeted inhibition of Prrx1 attenuated fibrotic remodeling in vivo with intra-tracheal antisense oligonucleotides in bleomycin mouse model of lung fibrosis and ex vivo using human and mouse precision-cut lung slices. Our results identified PRRX1 as a key mesenchymal transcription factor during lung fibrogenesis.

Data availability

For gene expression profiling, publicly available datasets were obtained from NCBI Gene Expression Omnibus (GSE2052, GSE24206 and GSE21411) , IPF Cell Atlas (www.ipfcellatlas.com) or FibroXplorer (www.fibroXplorer.com). Newly generated expression dataset has been deposited in the Gene Expression Omnibus GSE161364. All data generated or analyzed during this study are included in the manuscript and supporting files.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Emmeline Marchal-Duval

    Physiopathologie et épidémiologie des maladies respiratoires, Université Paris Cité, Inserm, Paris, France
    Competing interests
    No competing interests declared.
  2. Méline Homps-Legrand

    Physiopathologie et épidémiologie des maladies respiratoires, Université Paris Cité, Inserm, Paris, France
    Competing interests
    No competing interests declared.
  3. Antoine Froidure

    Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium
    Competing interests
    Antoine Froidure, received an unrestricted research grant from Boehringer Ingelheim, consulting fees from Boehringer Ingelheim and payment or honoraria from Boehringer Ingelheim and Roche that were paid to their institution. The author has no other competing interests to declare..
  4. Madeleine Jaillet

    Physiopathologie et épidémiologie des maladies respiratoires, Université Paris Cité, Inserm, Paris, France
    Competing interests
    No competing interests declared.
  5. Mada Ghanem

    Physiopathologie et épidémiologie des maladies respiratoires, Université Paris Cité, Inserm, Paris, France
    Competing interests
    No competing interests declared.
  6. Deneuville Lou

    Physiopathologie et épidémiologie des maladies respiratoires, Université Paris Cité, Inserm, Paris, France
    Competing interests
    No competing interests declared.
  7. Aurélien Justet

    Physiopathologie et épidémiologie des maladies respiratoires, Université Paris Cité, Inserm, Paris, France
    Competing interests
    No competing interests declared.
  8. Arnaud Maurac

    Physiopathologie et épidémiologie des maladies respiratoires, Université Paris Cité, Inserm, Paris, France
    Competing interests
    No competing interests declared.
  9. Aurelie Vadel

    Physiopathologie et épidémiologie des maladies respiratoires, Université Paris Cité, Inserm, Paris, France
    Competing interests
    No competing interests declared.
  10. Emilie Fortas

    Physiopathologie et épidémiologie des maladies respiratoires, Université Paris Cité, Inserm, Paris, France
    Competing interests
    No competing interests declared.
  11. Aurelie Cazes

    Physiopathologie et épidémiologie des maladies respiratoires, Université Paris Cité, Inserm, Paris, France
    Competing interests
    No competing interests declared.
  12. Audrey Joannes

    Institut de recherche en santé, environnement et travail, Univ Rennes, Inserm, EHESP, Rennes, France
    Competing interests
    No competing interests declared.
  13. Laura Giersh

    Physiopathologie et épidémiologie des maladies respiratoires, Université Paris Cité, Inserm, Paris, France
    Competing interests
    No competing interests declared.
  14. Herve Mal

    Service de Pneumologie et Transplantation, Assistance Publique - Hôpitaux de Paris, Paris, France
    Competing interests
    No competing interests declared.
  15. Pierre Mordant

    Physiopathologie et épidémiologie des maladies respiratoires, Université Paris Cité, Inserm, Paris, France
    Competing interests
    No competing interests declared.
  16. Tristan Piolot

    Collège de France, CNRS-UMR7241, INSERM-U1050, PSL Research University,, Paris, France
    Competing interests
    No competing interests declared.
  17. Marin Truchin

    Université Côte d'Azur, CNRS, Valbonne, France
    Competing interests
    No competing interests declared.
  18. Carine M Mounier

    Université Côte d'Azur, CNRS, Valbonne, France
    Competing interests
    No competing interests declared.
  19. Ksenija Schirduan

    Secarna Pharmaceuticals GmbH and Co KG, Planegg, Germany
    Competing interests
    Ksenija Schirduan, was a former employee of Secarna Pharmaceuticals..
  20. Martina Korfei

    Department of Internal Medicine II, University of Giessen, Gießen, Germany
    Competing interests
    No competing interests declared.
  21. Andreas Gunther

    Department of Internal Medicine, University of Giessen, Gießen, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2187-0975
  22. Bernard Mari

    Université Côte d'Azur, CNRS, Valbonne, France
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0422-9182
  23. Frank Jaschinski

    Secarna Pharmaceuticals GmbH and Co KG, Planegg, Germany
    Competing interests
    Frank Jaschinski, is an employee of Secarna Pharmaceuticals..
  24. Bruno Crestani

    Service de Pneumologie, Assistance Publique - Hôpitaux de Paris, Paris, France
    Competing interests
    Bruno Crestani, received grants from Boehringer Ingelheim, received consulting fees, payment or honoraria, and/or support for meetings and/or travel from Apellis, Astra Zeneca, BMS, Boehringer Ingelheim, Novartis, Sanofi. BC also participates on a data safety monitoring board or advisory board for Apellis, BMS, Boehringer Ingelheim, Sanofi and is a member on the Member of the board of trustee of the Fondation du Souffle. The author has no other competing interests to declare..
  25. Arnaud A Mailleux

    Physiopathologie et épidémiologie des maladies respiratoires, Université Paris Cité, Inserm, Paris, France
    For correspondence
    arnaud.mailleux@inserm.fr
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4191-1778

Funding

Agence Nationale de la Recherche (JCJC ANR-16-CE14-00)

  • Arnaud A Mailleux

European Respiratory Society (ERS-LTRF 2015 - 4476)

  • Antoine Froidure

Fondation pour la Recherche Médicale (FDT2021060129750)

  • Méline Homps-Legrand

Fondation pour la Recherche Médicale (FDM41320)

  • Aurélien Justet

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal experiments were conducted in accordance with the Directive 2010/63/EU of the European Parliament and approved by the local Animal ethics committee ("Comité d'éthique Paris Nord 121", APAFiS #4778 Etudedufacteurdetran_2016031617411315).

Human subjects: The study on human material was performed in accordance with the Declaration of Helsinki and approved by the local ethics committee (CPP Ile de France 1, No.0811760). Written informed consent was obtained from all subjects.

Reviewing Editor

  1. Melanie Königshoff, University of Pittsburgh, United States

Version history

  1. Preprint posted: January 15, 2021 (view preprint)
  2. Received: April 28, 2022
  3. Accepted: May 31, 2023
  4. Accepted Manuscript published: June 1, 2023 (version 1)
  5. Version of Record published: June 16, 2023 (version 2)

Copyright

© 2023, Marchal-Duval et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 641
    Page views
  • 128
    Downloads
  • 0
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Emmeline Marchal-Duval
  2. Méline Homps-Legrand
  3. Antoine Froidure
  4. Madeleine Jaillet
  5. Mada Ghanem
  6. Deneuville Lou
  7. Aurélien Justet
  8. Arnaud Maurac
  9. Aurelie Vadel
  10. Emilie Fortas
  11. Aurelie Cazes
  12. Audrey Joannes
  13. Laura Giersh
  14. Herve Mal
  15. Pierre Mordant
  16. Tristan Piolot
  17. Marin Truchin
  18. Carine M Mounier
  19. Ksenija Schirduan
  20. Martina Korfei
  21. Andreas Gunther
  22. Bernard Mari
  23. Frank Jaschinski
  24. Bruno Crestani
  25. Arnaud A Mailleux
(2023)
Identification of paired-related Homeobox Protein 1 as a key mesenchymal transcription factor in pulmonary fibrosis
eLife 12:e79840.
https://doi.org/10.7554/eLife.79840

Further reading

    1. Cell Biology
    2. Developmental Biology
    Simon Schneider, Andjela Kovacevic ... Hubert Schorle
    Research Article

    Cylicins are testis-specific proteins, which are exclusively expressed during spermiogenesis. In mice and humans, two Cylicins, the gonosomal X-linked Cylicin 1 (Cylc1/CYLC1) and the autosomal Cylicin 2 (Cylc2/CYLC2) genes, have been identified. Cylicins are cytoskeletal proteins with an overall positive charge due to lysine-rich repeats. While Cylicins have been localized in the acrosomal region of round spermatids, they resemble a major component of the calyx within the perinuclear theca at the posterior part of mature sperm nuclei. However, the role of Cylicins during spermiogenesis has not yet been investigated. Here, we applied CRISPR/Cas9-mediated gene editing in zygotes to establish Cylc1- and Cylc2-deficient mouse lines as a model to study the function of these proteins. Cylc1 deficiency resulted in male subfertility, whereas Cylc2-/-, Cylc1-/yCylc2+/-, and Cylc1-/yCylc2-/- males were infertile. Phenotypical characterization revealed that loss of Cylicins prevents proper calyx assembly during spermiogenesis. This results in decreased epididymal sperm counts, impaired shedding of excess cytoplasm, and severe structural malformations, ultimately resulting in impaired sperm motility. Furthermore, exome sequencing identified an infertile man with a hemizygous variant in CYLC1 and a heterozygous variant in CYLC2, displaying morphological abnormalities of the sperm including the absence of the acrosome. Thus, our study highlights the relevance and importance of Cylicins for spermiogenic remodeling and male fertility in human and mouse, and provides the basis for further studies on unraveling the complex molecular interactions between perinuclear theca proteins required during spermiogenesis.

    1. Cell Biology
    2. Structural Biology and Molecular Biophysics
    Bronwyn A Lucas, Benjamin A Himes, Nikolaus Grigorieff
    Research Advance

    Previously we showed that 2D template matching (2DTM) can be used to localize macromolecular complexes in images recorded by cryogenic electron microscopy (cryo-EM) with high precision, even in the presence of noise and cellular background (Lucas et al., 2021; Lucas et al., 2022). Here, we show that once localized, these particles may be averaged together to generate high-resolution 3D reconstructions. However, regions included in the template may suffer from template bias, leading to inflated resolution estimates and making the interpretation of high-resolution features unreliable. We evaluate conditions that minimize template bias while retaining the benefits of high-precision localization, and we show that molecular features not present in the template can be reconstructed at high resolution from targets found by 2DTM, extending prior work at low-resolution. Moreover, we present a quantitative metric for template bias to aid the interpretation of 3D reconstructions calculated with particles localized using high-resolution templates and fine angular sampling.